R01 LIVER
Active substance: LYCOPODIUM CLAVATUM SPORE, STRYCHNOS NUX-VOMICA SEED, MATRICARIA CHAMOMILLA, PHOSPHORUS, ADENOSINE TRIPHOSPHATE
SOLUTION/ DROPS · LYCOPODIUM CLAVATUM SPORE 7 [hp_C]/mL, STRYCHNOS NUX-VOMICA SEED 7 [hp_C]/mL, MATRICARIA CHAMOMILLA 7 [hp_C]/mL, PHOSPHORUS 7 [hp_C]/mL, ADENOSINE TRIPHOSPHATE 5 [hp_X]/mL
United StatesActive
Marketing holder: Apex Energetics Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LYCOPODIUM CLAVATUM SPORE · 7 [hp_C]/mL
- STRYCHNOS NUX-VOMICA SEED · 7 [hp_C]/mL
- MATRICARIA CHAMOMILLA · 7 [hp_C]/mL
- PHOSPHORUS · 7 [hp_C]/mL
- ADENOSINE TRIPHOSPHATE · 5 [hp_X]/mL
Registration
- Registration number
- 63479-1801
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 63479-1801 · Verified 2026-10-09 · open in source